๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

25 recruiting trials

for Diabetic Nephropathy Type 2

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus NCT05692388n/a1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Patient and Community Stakeholder Interviews, Cross-sectional Study Participants, Focus Groups and Intervention Mapping Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. NCT04931537n/a1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes NCT06586203NA2 sites๐Ÿ“ Montreal๐Ÿ“ Montreal Optithera ยท Tests: Polygenic Risk Score Real World Evidence Clinical Utility Study of KidneyIntelX NCT04802395n/a1 site๐Ÿ“ New York Renalytix AI, Inc. ยท Tests: KidneyIntelX Remote Ischemic Preconditioning in Type 2 Diabetic Patients Undergoing CABG NCT06977230NA2 sites๐Ÿ“ MuฤŸla๐Ÿ“ MuฤŸla MuฤŸla Sฤฑtkฤฑ Koรงman University ยท Tests: Remote Ischemic Preconditioning Mechanism of SGLT2 Inhibition in the Kidney NCT06291155Phase 41 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: SGLT2 inhibitor Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD) NCT07434791NA1 site๐Ÿ“ Toronto Sunnybrook Health Sciences Centre ยท Tests: Early goal-directed Cardio-Kidney-Metabolic (CKM) care, Standard care (Comparison arm) Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy NCT05888909n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy NCT03865914n/a1 site๐Ÿ“ Beijing Chinese PLA General Hospital Transformative Research in Diabetic Nephropathy 2.0 NCT07444203n/a1 site๐Ÿ“ Philadelphia University of Pennsylvania ยท Tests: Sodium-glucose cotransporter 2 inhibitors (SGLT2i), Renin-angiotensin-aldosterone system blockade, Glucagon-like peptidโ€ฆ Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial NCT07396155Phase 1, Phase 21 site๐Ÿ“ Yogyakarta PT. Prodia Stem Cell Indonesia ยท Tests: Umbilical Cord Mesenchymal Stem Cells Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease NCT07271186Phase 258 sites๐Ÿ“ Huntsville๐Ÿ“ Little Rock๐Ÿ“ Huntington Beach Regeneron Pharmaceuticals ยท Tests: ALN-ANG3, Evinacumab, Placebo Paraoxonase and HDL Qualities in Glycaemia and Inflammation NCT02169518n/a1 site๐Ÿ“ Manchester Manchester University NHS Foundation Trust Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes NCT06936670NA2 sites๐Ÿ“ Seattle๐Ÿ“ Seattle Seattle Children's Hospital ยท Tests: Inspiratory Muscle Strength Training (IMST), Sham Training Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community NCT05349955NA13 sites๐Ÿ“ Suzhou๐Ÿ“ Suzhou๐Ÿ“ Suzhou Shanghai Zhongshan Hospital ยท Tests: Intensive guideline algorithm implementation, Conventional guideline algorithm implementation Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes. NCT07026539Phase 41 site๐Ÿ“ Aarhus N University of Aarhus ยท Tests: Finerenone (BAY 94-8862), Placebo A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort NCT07024823Phase 15 sites๐Ÿ“ Glendale๐Ÿ“ Chicago๐Ÿ“ Ann Arbor AstraZeneca ยท Tests: AZD4248, Placebo, AZD4248, Placebo Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial NCT07485075NA2 sites๐Ÿ“ Herlev๐Ÿ“ Hillerรธd Steno Diabetes Center Copenhagen ยท Tests: StenoFood App Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132n/a13 sites๐Ÿ“ Skejby๐Ÿ“ Copenhagen๐Ÿ“ Hillerรธd Herlev Hospital ยท Tests: Kidney Biopsy PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes NCT05390892Phase 436 sites๐Ÿ“ Huntsville๐Ÿ“ Scottsdale๐Ÿ“ Los Angeles Brigham and Women's Hospital ยท Tests: SGLT2 inhibitor, GLP-1 receptor agonist Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study) NCT05008276n/a2 sites๐Ÿ“ Aurora๐Ÿ“ Seattle Petter Bjornstad ยท Tests: Aminohippurate Sodium Inj 20%, Iohexol Inj 300 MG/ML, Dextran 40 Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care NCT07169422NA1 site๐Ÿ“ Halifax Nova Scotia Health Authority ยท Tests: Usual care for diabetic kidney disease management without primary care provider., Pharmacist-led validated diabetic kidโ€ฆ Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) NCT05469659Phase 21 site๐Ÿ“ Matsumoto Shinshu University ยท Tests: Tofogliflozin, Metformin NAD Augmentation in Diabetes Kidney Disease NCT05759468Phase 21 site๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Investigational Product - MIB 626, Placebo Patients With Type 2 Diabetes NCT07245082n/a1 site๐Ÿ“ Taipei National Taiwan University Hospital
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy